This inventor holds 1 USPTO granted patent. Top assignee: Nantcell, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Oleksandr Buzko and Peptide Therapeutics Against SARS-CoV-2
Introduction
Oleksandr Buzko is an inventor associated with NantCell, Inc. His listed patent concerns peptide therapeutics targeting the SARS-CoV-2 spike protein.
Latest Patents
Buzko is credited with 1 patent: “Peptide Therapeutics Against SARS-COV-2 Spike Protein.” The invention focuses on peptide-based approaches directed at the viral spike protein.
Career Highlights
The available information identifies Buzko as an inventor working with NantCell, Inc., a company involved in biotechnology and therapeutic research.
Collaborations
Buzko’s listed coworkers include Jay Gardner Nelson and Wendy M. Higashide.
Conclusion
Oleksandr Buzko’s recorded patent highlights his contribution to research into peptide therapeutics targeting the SARS-CoV-2 spike protein.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile